1. Home
  2. KALA vs SLNH Comparison

KALA vs SLNH Comparison

Compare KALA & SLNH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • SLNH
  • Stock Information
  • Founded
  • KALA 2009
  • SLNH 1961
  • Country
  • KALA United States
  • SLNH United States
  • Employees
  • KALA N/A
  • SLNH N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • SLNH EDP Services
  • Sector
  • KALA Health Care
  • SLNH Technology
  • Exchange
  • KALA Nasdaq
  • SLNH Nasdaq
  • Market Cap
  • KALA 27.3M
  • SLNH 29.4M
  • IPO Year
  • KALA 2017
  • SLNH N/A
  • Fundamental
  • Price
  • KALA $6.64
  • SLNH $1.45
  • Analyst Decision
  • KALA Strong Buy
  • SLNH
  • Analyst Count
  • KALA 2
  • SLNH 0
  • Target Price
  • KALA $15.00
  • SLNH N/A
  • AVG Volume (30 Days)
  • KALA 108.1K
  • SLNH 511.7K
  • Earning Date
  • KALA 03-28-2025
  • SLNH 03-31-2025
  • Dividend Yield
  • KALA N/A
  • SLNH N/A
  • EPS Growth
  • KALA N/A
  • SLNH N/A
  • EPS
  • KALA N/A
  • SLNH N/A
  • Revenue
  • KALA N/A
  • SLNH $39,867,000.00
  • Revenue This Year
  • KALA N/A
  • SLNH N/A
  • Revenue Next Year
  • KALA N/A
  • SLNH N/A
  • P/E Ratio
  • KALA N/A
  • SLNH N/A
  • Revenue Growth
  • KALA N/A
  • SLNH 163.48
  • 52 Week Low
  • KALA $4.21
  • SLNH $1.36
  • 52 Week High
  • KALA $11.20
  • SLNH $8.80
  • Technical
  • Relative Strength Index (RSI)
  • KALA 39.29
  • SLNH 33.67
  • Support Level
  • KALA $6.50
  • SLNH $1.36
  • Resistance Level
  • KALA $8.65
  • SLNH $1.75
  • Average True Range (ATR)
  • KALA 0.90
  • SLNH 0.16
  • MACD
  • KALA -0.43
  • SLNH -0.01
  • Stochastic Oscillator
  • KALA 2.98
  • SLNH 17.65

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About SLNH Soluna Holdings Inc.

Soluna Holdings Inc is a U.S.-based company that conducts operations through its subsidiary. The group is engaged in the mining of cryptocurrency through data centers that can be powered by renewable energy sources. The data centers buy every excess megawatt to use for batch-oriented, computing-intensive processes such as cryptocurrency mining or machine learning which is a low-risk and low-friction solution to use as a smartphone.

Share on Social Networks: